WASHINGTON (Reuters) - As the U. S. Department of Justice's Civil Division charged with dealing with counterfeit and counterfeit pharmaceutical products is being prosecuted, it may be the beginning of another crackdown.
The Department of Justice has accused a New York-based company of selling counterfeit versions of aspirin, a painkiller and a popular cough medicine to pharmacies in the United States.
"Counterfeit pharmaceutical products have caused significant harm to consumers, including the spread of counterfeit versions of pain relievers, fever reducers and cough-relief medications," the agency said in a statement on Tuesday.
The investigation was launched by the U. Food and Drug Administration (FDA) and the U. Department of Justice's Civil Division. The agency said it had found that Pfizer Inc, a generic manufacturer of prescription pain relievers, was selling counterfeit versions of aspirin and cough-relief medications.
The investigation is ongoing.
The company was named in a criminal complaint by the New York-based company, the federal Justice Department said.
"We believe this criminal complaint is in the best interest of consumers and that consumers should be advised of the possible risks and consequences associated with the sale of these products," the Justice Department said in a statement on Tuesday.
The drug, a type of over-the-counter (OTC) painkiller, is sold as a single-dose and is not widely available to patients and doctors, according to the FDA.
A Pfizer spokeswoman declined to comment. The company did not immediately return phone messages seeking comment from Reuters.
In the case of ibuprofen, a prescription-strength, nonsteroidal anti-inflammatory drug that can be taken with or without food, the FDA said the product was made by GlaxoSmithKline. In one of the products, Pfizer said, it added that it could not be reached for comment.
The company said it would continue to market and sell the drug without the supervision of a doctor, and it said the drug was being sold by the company at a retail pharmacy.
The Food and Drug Administration said it was working with the Department of Justice to investigate the alleged violation of international trade law. It said in a statement the government and the government's response will be used to secure the arrest and forfeiture of assets, and may be used as a means to further investigations.
The FDA said it had not received any information about the alleged violations of international trade law.
"This civil probe is an appropriate response to the government's investigation and will not have any impact on the criminal proceedings," it said.
The drug has been seized in the United States and abroad by U. authorities, according to the FDA.
APA statement from the Department of Justice's Civil Division said it was acting "to ensure appropriate actions are taken." The agency has not received any information about the alleged criminal activity and does not plan to launch further criminal or civil proceedings against the company.
"The Department of Justice will continue to pursue any appropriate actions against the company that are necessary to investigate and bring charges," it said.
Copyright 2025 Reuters. All Rights Reserved.
Reporting by Linda A. Johnson in New York, including stories by The Associated Press, Esquire, The Wall Street Journal, The New York Post, The Wall Street Journal, Financial Times, the London(r) and British Medical Journal.Reporting by Richard G. Danziger in New York; by Leslie A. Taylor in New Jersey; by Michael F. Alpert in Washington; by Eric T. Lechleiter in Miami; by Jonathan F. Allison in San Francisco; by Robert M. Merrell in Washington; by David E. Rieser in Philadelphia; and by Kevin A. O'Brien in Inglewood, La. This material is intended for information purposes only.This content is not intended to substitute for the advice or professional judgment of a person or any other medical professional. This content is intended for informational purposes only and does not constitute medical or medical advice. This content is not a substitute for the expertise and judgment of your physician or other healthcare professional. This content is not intended to be a substitute for the knowledge, experience, judgment, or responsiveness of your own healthcare professional. You should not rely upon the specific statements or opinions of this website for specific medical, health, legal, health or helpful advice or guidance regarding treatment or treatment for you.
By:Dr. Jane Smith
About the patientThe patient is a woman who lives in New Jersey, but is not an American citizen. She lives in Brooklyn and is not a citizen, and is not eligible to vote. Her pregnancy is due to her mother's illness. The patient has never been prescribed the pain reliever ibuprofen. The patient is an American citizen of New Jersey. She is not eligible to vote. The patient is not an American citizen.
The patient has been diagnosed with an autoimmune disease called. The patient has not been prescribed the pain reliever. She is an American citizen.
The patient is an American citizen of Brooklyn. She is not an American citizen and has not been prescribed ibuprofen.
What does this mean for you?
I'm a patient, but I am not an American citizen. I am not an American citizen.
What are your other medical conditions?
I'm not an American citizen.
What other medical conditions do you have?
What kind of medication do you take?
What are your current medications?
What is the best treatment for a particular medical condition?
I am an American citizen of New Jersey.
How do you manage your health?
Are there any special medications I can take?
What are the possible side effects of ibuprofen?
What are some common side effects of ibuprofen?
Can you tell me about ibuprofen for pain?
Are there any common medical problems that affect me?
What medications are there for you?
What are your other medications?
I'm an American citizen.
I am an American citizen.
The purpose of this study was to determine the pka value of ibuprofen in water and the effects of different concentrations of ibuprofen on the stability of the drug in water and on its excretion.
Materials and Methods
We developed a new model for the stability study of ibuprofen in water. The experimental data was obtained using a computerized model in the form of a model with three independent equations, the stability was determined by the following:
$$\frac{{d\text{pka}}_{i} - \frac{{d\text{pka}}_{c}}{{d\text{pka}}_{c}}}{{{\text{t}}_{i} - \text{t}}}}$$where
$i$ and
$c$ are the pka value of the drug in the water and in the initial drug,
$d\text{pka}_{i}$ and
$d\text{pka}_{c}$ are the pka value of the drug in the drug and initial drug, and
$\text{t}$ and
$\text{t}_{i}$ are the time-dependent concentration of drug in the water (i.e., the time it takes for the drug to be destroyed by the degradation of its structure).
The values of the concentration for drug in water and the time-dependent concentration of drug in the drug in the drug was calculated by the following formula:
Where
$c$ are the pka value of drug in water and in the initial drug, and
$d\text{pka}_{c}$ are the pka value of drug in drug and initial drug, respectively. The experimental data for the stability of drug in water were obtained using a computerized model with three independent equations. The data was obtained from the original model, and the stability of drug in water was determined by the following formula:
$\text{t}_{i}$ are the time-dependent concentration of drug in water.
The results of the drug stability in water and in the drug in initial drug were obtained using the model obtained from the original model.
Results
In order to determine the effect of ibuprofen on the stability of the drug in water, the effect of the concentration of ibuprofen on the stability of drug in initial drug and in initial drug was studied by the following formula:
$c$ are the pka value of drug in water and initial drug, and
The pka value of drug in initial drug and the time-dependent concentration of drug in initial drug were determined using the model obtained from the original model.
The most common side effects of ibuprofen include: stomach ache, heartburn, indigestion, back pain, muscle aches, joint pain, headache, nausea, dry skin, joint pain, muscle pain, and joint stiffness.
More common side effects include: back pain, muscle pain, joint pain, nausea, fever, and headache.
If you experience these symptoms, stop taking ibuprofen and see your doctor immediately. Your doctor will likely start you on a lower dose and gradually increase it over a period of time.
The recommended dose is 200 mg (NSAID) every 4-6 hours, but your doctor may adjust it based on your condition and response to treatment.
If your condition is not improving, or if you continue to have stomach ache, you may need to take ibuprofen for another week or more. If you have been taking it regularly for long periods of time, you may not feel the full benefit of the medication.
In some cases, your doctor may advise you to take ibuprofen for short-term relief of pain.
If you experience fever, pain, joint pain, muscle pain, muscle weakness, or a change in your sense of well-being, contact your doctor.
Some NSAIDs, including ibuprofen and naproxen, are known as anti-inflammatory drugs (or “AED”).
They work by blocking the production of chemicals that cause inflammation.
They are generally taken in tablet form and are well tolerated.
They work well to relieve mild to moderate pain and flu symptoms.
They are effective at reducing fever and relieving minor aches and pains associated with the common cold or flu.
The most common side effects of these drugs are:
The side effects of these drugs include:
You may notice a few minor side effects. These are more common or more serious:
If you notice these serious side effects, contact your doctor immediately. You may also need medical attention.
Each ibuprofen tablet contains 200 mg of the active ingredient called ibuprofen. The dosage is based on your body weight. The standard dose is 400 mg. Depending on your condition, you may need to take a dose of 200 mg every 4-6 hours.
You can take the tablets with or without food, but they should be taken at least 30 minutes to 1 hour before your next dose of ibuprofen.
The tablets should not be split or crushed as this can reduce the drug’s effectiveness.
The active ingredient in the tablets should be absorbed through the skin, not through the gastrointestinal tract.
Ibuprofen is available as a liquid suspension.
The maximum recommended dose of ibuprofen is 400 mg per day, taken for 3-6 days. If you are taking aspirin to prevent a heart attack or stroke, you should not take more than 400 mg per day.
Ibuprofen is taken once a day. It should be taken at least 1 hour before and 1 hour after a meal. It should not be taken more than once in a 24-hour period.
If you are taking other medications or supplements, tell your doctor or pharmacist about all the products you use. This includes prescription drugs, over-the-counter medicines, dietary supplements, and herbal products.
Always read the label or use a health food guide to avoid possible drug interactions.
Ibuprofen may make your skin more sensitive to sunlight and may reduce the effectiveness of sunscreens.
Buy Ibuprofen from Walmart, CVS, Target, or your local pharmacy. If you have any questions, consult your doctor or pharmacist.Ibuprofen and ibuprofen-containing topical pain relievers (e.g., paracetamol) are two commonly used topical pain relievers and their primary use for the management of acute pain in infants, children, and adults. Although each is effective for minor aches and pains, their primary use has been to reduce fever in the presence of fever, which is a common side effect associated with these drugs. The main objective of this study was to assess the effect of ibuprofen and ibuprofen-containing topical pain relievers (e.g., paracetamol) for infants, children, and adults with acute uncomplicated minor aches and pains (acute uncomplicated/fever associated with fever) on pain relief.
The primary goal of this study was to assess the effects of ibuprofen and ibuprofen-containing topical pain relievers (e.g., paracetamol) for infants, children, and adults with acute uncomplicated minor aches and pains (acute uncomplicated/fever associated with fever) on pain relief. Secondary objectives included assessment of pain, fever, and clinical effects (e.g., signs, symptoms, and quality of life) during acute uncomplicated minor aches and pains and to assess the effects of ibuprofen and ibuprofen-containing topical pain relievers (e.g., paracetamol) on pain relief. Patients were divided into two groups: group 1 (n = 9) received ibuprofen (0.5 mg/kg/day) and ibuprofen-containing topical pain relievers (1 mg/kg/day) for the first 7 days; group 2 (n = 8) received ibuprofen (0.5 mg/kg/day) and ibuprofen-containing topical pain relievers (1 mg/kg/day) for the first 7 days. Group 1 was included in a parallel group of patients with a history of acute uncomplicated minor aches and pains. Group 2 was included in a parallel group of patients with a history of acute uncomplicated minor aches and pains (n = 9). Both groups were evaluated in terms of pain, fever, and clinical effects during acute uncomplicated minor aches and pains.
Stade de France Pharmacy